Protagonist Therapeutics Inc

NASDAQ:PTGX 4:00:00 PM EDT

22.74

-0.04 (-0.18%)

4:55:03 PM EDT: $22.28 -0.46 (-2.02%)

Market Cap (Intraday)	1.17B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2 Million
Adjusted EPS	-$0.73

See more estimates

10-Day MA	$22.61
50-Day MA	$16.46
200-Day MA	$10.81

See more pivots

Protagonist Therapeutics Inc Stock, NASDAQ:PTGX

7707 Gateway Boulevard, Suite 140, Newark, California 94560-1160

Phone: +1.510.474.0170

Number of Employees: 105

http://www.protagonist-inc.com

Description

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.